文献速递流行病学与生物统计基础与转化研究

基于生存数据的稳健最优治疗决策方法

Robust method for optimal treatment decision making based on survival data.
PubMed 文献 · Stat Med · 2021-09-22

针对存在治疗效应异质性的生存数据,提出基于灵活半参数加速失效时间模型的最优治疗决策规则估计方法,仅参数化治疗对比,采用AIPWE稳健估计并最小化治疗对比间损失,可结合惩罚项选择决策变量,模拟研究及ACTG 175试验展示其性能。

要点

  • 提出的损失函数基于完全决定最优治疗规则的治疗对比。
  • 可纳入惩罚项选择仅对治疗决策重要的变量,同时利用全部预测协变量。
  • 方法在ACTG 175临床试验中进行了应用展示。

核心结论

  • 提出了基于生存数据估计最优治疗决策规则的稳健方法。
  • 方法仅参数化治疗对比,其余部分未指定,具有灵活性。

研究设计与样本

  • 基于灵活半参数加速失效时间模型,仅参数化治疗对比。
  • 采用AIPWE稳健估计个体治疗对比,再最小化与AIPWE对比的损失。
  • 提出两种考虑删失的损失函数,并可结合惩罚项选择变量。
  • 通过综合模拟研究评估方法性能,并应用于ACTG 175临床试验。

主要发现

  • 所提出的损失函数基于治疗对比,完全决定最优治疗规则。
  • 方法可结合惩罚项选择仅对治疗决策重要的变量,同时利用全部预测协变量改善性能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Identifying the optimal treatment decision rule, where the best treatment for an individual varies according to his/her characteristics, is of great importance when treatment effect heterogeneity exists. We develop methods for estimating the optimal treatment decision rule based on data with survival time as the primary endpoint. Our methods are based on a flexible semiparametric accelerated failure time model, where only the treatment contrast (ie, the difference in means between treatments) is parameterized and all other aspects are unspecified. An individual's treatment contrast is firstly estimated robustly by an augmented inverse probability weighted estimator (AIPWE). Then the optimal decision rule is estimated by minimizing the loss between the treatment contrast and the AIPWE contrast. Two loss functions with different strategies to account for censoring are proposed. The proposed loss functions distinguish from existing ones in that they are based on treatment contrasts, which completely determine the optimal treatment rule. Our methods can further incorporate a penalty term to select variables that are only important for treatment decision making, while taking advantage of all covariates predictive of outcomes to improve performance. Comprehensive simulation studies have been conducted to evaluate performances of the proposed methods relative to existing methods. The proposed methods are illustrated with an application to the ACTG 175 clinical trial on HIV-infected patients.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Fang Y, Zhang B, Zhang M, et al. Robust method for optimal treatment decision making based on survival data. Stat Med. 2021. PMID: 34549828. doi:10.1002/sim.9198

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。